| Title |
Claudin-containing exosomes in the peripheral circulation of women with ovarian cancer
|
|---|---|
| Published in |
BMC Cancer, July 2009
|
| DOI | 10.1186/1471-2407-9-244 |
| Pubmed ID | |
| Authors |
Jianghong Li, Cheryl A Sherman-Baust, Miyun Tsai-Turton, Robert E Bristow, Richard B Roden, Patrice J Morin |
| Abstract |
The absence of highly sensitive and specific serum biomarkers makes mass screening for ovarian cancer impossible. The claudin proteins are frequently overexpressed in ovarian cancers, but their potential as prognostic, diagnostic, or detection markers remains unclear. Here, we have explored the possible use of these proteins as screening biomarkers for ovarian cancer detection. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 180 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 4 | 2% |
| Chile | 2 | 1% |
| Denmark | 2 | 1% |
| New Zealand | 1 | <1% |
| India | 1 | <1% |
| Argentina | 1 | <1% |
| Unknown | 169 | 94% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 45 | 25% |
| Student > Ph. D. Student | 41 | 23% |
| Student > Master | 24 | 13% |
| Student > Bachelor | 10 | 6% |
| Student > Doctoral Student | 8 | 4% |
| Other | 21 | 12% |
| Unknown | 31 | 17% |
| Readers by discipline | Count | As % |
|---|---|---|
| Biochemistry, Genetics and Molecular Biology | 45 | 25% |
| Agricultural and Biological Sciences | 39 | 22% |
| Medicine and Dentistry | 31 | 17% |
| Immunology and Microbiology | 7 | 4% |
| Engineering | 7 | 4% |
| Other | 15 | 8% |
| Unknown | 36 | 20% |
Attention Score in Context
This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 March 2021.
All research outputs
#3,178,012
of 22,691,736 outputs
Outputs from BMC Cancer
#728
of 8,252 outputs
Outputs of similar age
#12,354
of 110,491 outputs
Outputs of similar age from BMC Cancer
#7
of 51 outputs
Altmetric has tracked 22,691,736 research outputs across all sources so far. Compared to these this one has done well and is in the 85th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 8,252 research outputs from this source. They receive a mean Attention Score of 4.3. This one has done particularly well, scoring higher than 90% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 110,491 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 51 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 86% of its contemporaries.